Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases.

biomarker hepatocellular carcinoma omics precision medicine

Journal

Hepatology research : the official journal of the Japan Society of Hepatology
ISSN: 1386-6346
Titre abrégé: Hepatol Res
Pays: Netherlands
ID NLM: 9711801

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 01 04 2020
revised: 13 04 2020
accepted: 18 04 2020
pubmed: 24 4 2020
medline: 24 4 2020
entrez: 24 4 2020
Statut: ppublish

Résumé

Precise hepatocellular carcinoma (HCC) risk prediction will play increasingly important roles with the contemporary HCC etiologies, that is, non-alcoholic fatty liver disease and resolved hepatitis C virus infection. Because the HCC incidence rate in this emerging patient population is relatively low (~1% per year), identification of a subset of patients at the highest risk is critical to concentrate the effort and resources of regular HCC screening to those who most need it. Omics profiling has been derived using several candidate HCC risk biomarkers, which could refine HCC screening by enabling individual risk-based personalized or risk-stratified patient management. Various types of biomolecules have been explored as sources of information to predict HCC risk at various time horizons. Germline DNA polymorphisms likely reflect race/ethnicity- and/or etiology-specific susceptibility to HCC development or chronic liver disease progression toward carcinogenesis. Transcriptomic dysregulations in the diseased liver capture functional molecular status supporting oncogenesis such as inflammatory pathway and myofibroblast activation. Circulating nucleic acids, proteins, and metabolites could serve as less-invasive measures of molecular HCC risk. Characterization of gut microbiota could also inform HCC risk estimation. Each biomarker could have its niche of clinical application depending on logistics of use, performance, and costs with a goal to eventually improve patient prognosis as a part of the whole algorithm of chronic liver disease management.

Identifiants

pubmed: 32323426
doi: 10.1111/hepr.13506
pmc: PMC8318383
mid: NIHMS1723795
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

817-830

Subventions

Organisme : NCI NIH HHS
ID : U01 CA226052
Pays : United States
Organisme : Uehara Memorial Foundation
ID : DK099558
Organisme : Uehara Memorial Foundation
ID : CA226052
Organisme : European Commission
ID : ERC-2014-AdG-671231
Organisme : Cancer Prevention and Research Institute of Texas
ID : RR180016
Organisme : NIDDK NIH HHS
ID : R01 DK099558
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA233794
Pays : United States
Organisme : European Research Council
ID : 671231
Pays : International
Organisme : Uehara Memorial Foundation
ID : CA233794

Informations de copyright

© 2020 The Japan Society of Hepatology.

Références

Hepatology. 2010 Sep;52(3):894-903
pubmed: 20684021
Cancers (Basel). 2019 Oct 06;11(10):
pubmed: 31590436
BMC Med Genet. 2019 Aug 16;20(1):142
pubmed: 31419949
Cell Metab. 2017 May 2;25(5):1054-1062.e5
pubmed: 28467925
Clin Cancer Res. 2013 Apr 1;19(7):1827-37
pubmed: 23426277
Lancet. 2015 Oct 17;386(10003):1546-55
pubmed: 26231459
Sci Rep. 2019 May 17;9(1):7536
pubmed: 31101866
Nat Commun. 2014 Jun 30;5:4309
pubmed: 24978903
PLoS Med. 2014 Dec 23;11(12):e1001770
pubmed: 25536056
Hepatol Res. 2018 Feb;48(2):127-133
pubmed: 29235266
Hepatology. 2017 Oct;66(4):1344-1346
pubmed: 28390144
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1317-25
pubmed: 25646427
Nat Genet. 2011 Jul 03;43(8):797-800
pubmed: 21725309
J Gastroenterol. 2014 Jul;49(7):1152-62
pubmed: 23860735
Hepatology. 2018 Feb;67(2):662-675
pubmed: 28960374
Am J Gastroenterol. 2014 Mar;109(3):325-34
pubmed: 24445574
Gastroenterology. 2016 May;150(5):1208-1218
pubmed: 26774178
JAMA. 2017 Jan 24;317(4):388-406
pubmed: 28118455
Sci Rep. 2018 Oct 10;8(1):15058
pubmed: 30305682
Nature. 2018 Jun;558(7708):73-79
pubmed: 29875488
Clin Transl Gastroenterol. 2017 Jun 22;8(6):e101
pubmed: 28640287
Lancet Oncol. 2015 Jul;16(7):804-15
pubmed: 26088272
Hepatology. 2018 Aug;68(2):723-750
pubmed: 29624699
Gut. 2019 Jun;68(6):1014-1023
pubmed: 30045880
Gastroenterology. 2016 May;150(5):1219-1230.e6
pubmed: 26850495
N Engl J Med. 2019 Dec 19;381(25):2440-2450
pubmed: 31851800
Gastroenterology. 2018 Dec;155(6):1828-1837.e2
pubmed: 30144434
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Gastroenterology. 2013 May;144(5):1024-30
pubmed: 23333348
Hepatol Res. 2017 Mar;47(4):303-311
pubmed: 27126090
Nat Genet. 2009 Oct;41(10):1100-4
pubmed: 19749758
Sci Rep. 2017 Jul 3;7(1):4492
pubmed: 28674415
Nature. 2009 Sep 17;461(7262):399-401
pubmed: 19684573
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
Clin Gastroenterol Hepatol. 2019 Apr;17(5):976-987.e4
pubmed: 30616961
N Engl J Med. 2018 Mar 22;378(12):1096-1106
pubmed: 29562163
J Hepatol. 2015 Jul;63(1):131-40
pubmed: 25724366
Gut. 2015 Aug;64(8):1296-302
pubmed: 25143343
Ann N Y Acad Sci. 2019 Mar;1440(1):23-35
pubmed: 30221358
Br J Cancer. 2015 Mar 31;112(7):1141-56
pubmed: 25826224
Sci Rep. 2017 Mar 07;7:43238
pubmed: 28266614
Hepatology. 2019 Jul;70(1):231-240
pubmed: 30908678
Gastroenterology. 2017 Oct;153(4):996-1005.e1
pubmed: 28642197
Mol Metab. 2019 Apr;22:49-61
pubmed: 30772256
J Gastroenterol Hepatol. 2015 Feb;30(2):379-88
pubmed: 25168107
J Gastroenterol. 2011 Oct;46(10):1230-7
pubmed: 21748549
Gut. 2016 Oct;65(10):1754-64
pubmed: 26045137
J Hepatol. 2019 Aug;71(2):409-421
pubmed: 31004682
Hepatology. 2015 Aug;62(2):481-95
pubmed: 25833323
J Hepatol. 2013 Sep;59(3):504-9
pubmed: 23665287
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6308-6312
pubmed: 30858324
Gastroenterology. 2018 Aug;155(2):542-556
pubmed: 29702115
Hepatology. 2020 Jul;72(1):88-102
pubmed: 31630428
Gastroenterology. 2017 Jan;152(1):53-67.e3
pubmed: 27773806
Hepatology. 2016 Feb;63(2):418-27
pubmed: 26517016
Hepatology. 2011 Mar;53(3):791-9
pubmed: 21319195
Gastroenterology. 2019 Nov;157(5):1383-1397.e11
pubmed: 31344396
Hepatology. 2020 Sep;72(3):845-856
pubmed: 32190914
Nat Genet. 2011 May;43(5):455-8
pubmed: 21499248
Gastroenterology. 2017 May;152(6):1383-1394
pubmed: 28163062
Int J Cancer. 2019 Feb 1;144(3):533-544
pubmed: 30289982
Clin Gastroenterol Hepatol. 2015 May;13(5):1017-24
pubmed: 25460552
Clin Gastroenterol Hepatol. 2016 Jan;14(1):124-31.e1
pubmed: 26196445
Hepatology. 2016 Dec;64(6):2015-2027
pubmed: 27639192
Nat Rev Genet. 2016 Aug 16;17(9):507-22
pubmed: 27528417
BMC Med Genet. 2012 Jun 19;13:47
pubmed: 22712471
J Gen Intern Med. 2012 Jul;27(7):861-7
pubmed: 22215266
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8913-8
pubmed: 24927523
Nat Genet. 2013 Jan;45(1):72-5
pubmed: 23242368
J Hepatol. 2020 May;72(5):990-1002
pubmed: 32044402
Adv Drug Deliv Rev. 2017 Nov 1;121:27-42
pubmed: 28506744
Elife. 2019 Oct 17;8:
pubmed: 31621579
Asian Pac J Cancer Prev. 2013;14(5):2865-9
pubmed: 23803045
Hepatology. 2019 Apr;69(4):1504-1519
pubmed: 30415504
Cell. 2019 Apr 18;177(3):608-621.e12
pubmed: 30955891
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604
pubmed: 31439937
Medicine (Baltimore). 2019 Sep;98(38):e17275
pubmed: 31568008
Hepatology. 2016 Jul;64(1):34-46
pubmed: 26822232
Clin Gastroenterol Hepatol. 2020 Apr;18(4):935-944.e3
pubmed: 31419571
Hepatol Commun. 2019 Dec 19;4(2):284-297
pubmed: 32025611
Gastroenterology. 2019 Nov;157(5):1264-1278.e4
pubmed: 31356807
Nat Genet. 2015 Dec;47(12):1443-8
pubmed: 26482880
Hepatology. 2014 Oct;60(4):1291-301
pubmed: 24923488
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
Sci Rep. 2015 Nov 05;5:16278
pubmed: 26538132
J Viral Hepat. 2019 Oct;26(10):1233-1236
pubmed: 31177595
Gut. 2018 Aug;67(8):1493-1504
pubmed: 29437870
Nat Genet. 2014 Apr;46(4):352-6
pubmed: 24531328
BMC Med Genet. 2019 Apr 4;20(1):59
pubmed: 30947687
J Gastroenterol. 2018 Mar;53(3):438-448
pubmed: 28744823
Nature. 2009 Oct 8;461(7265):798-801
pubmed: 19759533
Hepatol Res. 2015 Jun;45(6):645-55
pubmed: 25070147
N Engl J Med. 2008 Nov 6;359(19):1995-2004
pubmed: 18923165
Nat Genet. 2008 Dec;40(12):1461-5
pubmed: 18820647
Hepatology. 2017 May;65(5):1526-1542
pubmed: 28027591
Nat Immunol. 2015 Dec;16(12):1235-44
pubmed: 26502405
Liver Int. 2014 Apr;34(4):514-20
pubmed: 24102786
EBioMedicine. 2017 Feb;15:81-89
pubmed: 27998720
Hepatol Res. 2020 Feb;50(2):246-257
pubmed: 31652385
Nat Genet. 2010 Sep;42(9):755-8
pubmed: 20676096
Clin Gastroenterol Hepatol. 2011 May;9(5):428-33; quiz e50
pubmed: 21320639
Cancer Cell. 2012 Apr 17;21(4):504-16
pubmed: 22516259
Cancer Cell. 2016 Dec 12;30(6):879-890
pubmed: 27960085
Aliment Pharmacol Ther. 2019 Sep;50(6):684-695
pubmed: 31250467
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2650-2666
pubmed: 31401364
J Hepatol. 2020 Feb;72(2):230-238
pubmed: 31954488
Hepatology. 2020 Jan;71(1):56-66
pubmed: 31155741
Nat Med. 2019 May;25(5):805-813
pubmed: 31011203
J Hepatol. 2018 Mar;68(3):526-549
pubmed: 28989095
Hepatology. 2011 Mar;53(3):1020-2
pubmed: 21374666
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760
Sci Rep. 2017 Sep 19;7(1):11912
pubmed: 28928439
Nat Genet. 2009 Oct;41(10):1105-9
pubmed: 19749757
J Gastrointestin Liver Dis. 2019 Dec 09;28(4):449-456
pubmed: 31826071
Am J Gastroenterol. 2018 Oct;113(10):1475-1483
pubmed: 29535416
BMC Cancer. 2019 Nov 21;19(1):1128
pubmed: 31752753
Nat Mater. 2017 Nov;16(11):1155-1161
pubmed: 29035356
J Gastroenterol. 2019 Apr;54(4):367-376
pubmed: 30498904

Auteurs

Naoto Fujiwara (N)

Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Tongqi Qian (T)

Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Bhuvaneswari Koneru (B)

Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Yujin Hoshida (Y)

Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Classifications MeSH